A randomized, double-blind, single-dose, single-center, parallel phase I clinical study comparing the pharmacokinetics, immunogenicity, safety, and tolerance of pertuzumab injection and Perjeta ® in healthy Chinese male subjects

.

Source: Expert Opinion on Biological Therapy - October 18, 2021 Category: Drugs & Pharmacology Authors: Guangwen Liu Zhongnan Xu Wei Yang Jinling Xue Yanli Wang Zhengzhi Liu Yingzi Cui Xinyao Qu Tianying Chang Shuang Yu Yang Cheng Yannan Zhou Jiahui Chen Qing Ren Wanhua Wang Qiaohuan Deng Zeyu Wang Haimiao Yang Source Type: research